Abstract
HTA235 Comparative Narrative Review of Oncology Value Assessment Frameworks: Enfortumab Vedotin (EV) for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have